Cargando…
Gene Therapy for Color Blindness
Achromatopsia is a rare congenital cause of vision loss due to isolated cone photoreceptor dysfunction. The most common underlying genetic mutations are autosomal recessive changes in CNGA3, CNGB3, GNAT2, PDE6H, PDE6C, or ATF6. Animal models of Cnga3, Cngb3, and Gnat2 have been rescued using AAV gen...
Autores principales: | Hassall, Mark M., Barnard, Alun R., MacLaren, Robert E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
YJBM
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5733843/ https://www.ncbi.nlm.nih.gov/pubmed/29259520 |
Ejemplares similares
-
Molecular Therapies for Choroideremia
por: Cehajic Kapetanovic, Jasmina, et al.
Publicado: (2019) -
RNA Editing as a Therapeutic Approach for Retinal Gene Therapy Requiring Long Coding Sequences
por: Fry, Lewis E., et al.
Publicado: (2020) -
Immunomodulatory Effects of Hydroxychloroquine and Chloroquine in Viral Infections and Their Potential Application in Retinal Gene Therapy
por: Chandler, Laurel C., et al.
Publicado: (2020) -
The Biological Activity of AAV Vectors for Choroideremia Gene Therapy Can Be Measured by In Vitro Prenylation of RAB6A
por: Patrício, Maria I., et al.
Publicado: (2018) -
Impact of Vital Dyes on Cell Viability and Transduction Efficiency of AAV Vectors Used in Retinal Gene Therapy Surgery: An In Vitro and In Vivo Analysis
por: Salvetti, Anna P., et al.
Publicado: (2017)